J. Jolkkonen et al., ACUTE AND SUBCHRONIC EFFECTS OF DOPAMINE AGONISTS ON NEUROPEPTIDE GENE-EXPRESSION IN THE RAT STRIATUM, Neuropeptides, 29(2), 1995, pp. 109-114
Acute and subchronic (7 days) effects of subcutaneous administration o
f the D-l agonist (SKF 38393; 5.0 mg/kg), the D-2 agonist (quinpirole;
5.0 mg/kg), the mixed D-1/D-2 agonist (apomorphine; 5.0 mg/kg) or per
golide (0.5 mg/kg) on enkephalin and substance P gene expression in th
e striatum were studied in rats using in situ hybridization. Striatal
enkephalin mRNA levels were unaffected by acute dopamine agonist treat
ment despite animals exhibiting altered motor behaviour. Only acute ap
omorphine treatment increased substance P mRNA (25%, p < 0.01). Follow
ing subchronic administration of pergolide, enkephalin mRNA expression
was decreased by 23% (p < 0.05) while other drugs were without effect
. The abundance of striatal substance P mRNA was increased only follow
ing subchronic pergolide treatment (35%, p < 0.05). These data suggest
that peptide gene expression in the intact striatum is relatively res
istent to intermittent dopamine agonist stimulation in contrast to the
pronounced alterations previously observed in 6-hydroxydopamine lesio
ned rats or following blockade of dopamine receptors.